In cancer cells, ACF has been shown to inhibit the unfolded protein response (UPR) pathway via inhibition of eukaryotic translation initiation factor 2A (eiF2a) phosphorylation and downregulation of the activating transcription factor 4 (ATF4) transcriptional program (82). The gene discussed is EIF2A; the disease is cancer.